Janux Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Janux Therapeutics Total Assets Growth & History (JANX)
Janux Therapeutics's total assets was $1.00B for fiscal 2025.
View full Janux Therapeutics company overviewJanux Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.00B | −$60.0M | −5.65% |
| 2024 | 2024-12-31 | $1.06B | $681.1M | +179.05% |
| 2023 | 2023-12-31 | $380.4M | $16.4M | +4.50% |
| 2022 | 2022-12-31 | $364.0M | −$15.8M | −4.16% |
| 2021 | 2021-12-31 | $379.8M | $363.6M | +2242.13% |
| 2020 | 2020-12-31 | $16.2M | — | — |
Janux Therapeutics quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.01B | −$24.6M | −2.38% |
| Q1 2026 | 2026-03-31 | $1.03B | −$22.5M | −2.15% |
| Q4 2025 | 2025-12-31 | $1.00B | −$60.0M | −5.65% |
| Q3 2025 | 2025-09-30 | $1.02B | $329.7M | +47.44% |
| Q2 2025 | 2025-06-30 | $1.03B | $340.8M | +49.29% |
| Q1 2025 | 2025-03-31 | $1.05B | $361.8M | +52.51% |
| Q4 2024 | 2024-12-31 | $1.06B | $681.1M | +179.05% |
| Q3 2024 | 2024-09-30 | $695.0M | $308.2M | +79.66% |
| Q2 2024 | 2024-06-30 | $691.4M | $349.9M | +102.46% |
| Q1 2024 | 2024-03-31 | $689.0M | $336.0M | +95.20% |
| Q4 2023 | 2023-12-31 | $380.4M | $16.4M | +4.50% |
| Q3 2023 | 2023-09-30 | $386.9M | $11.1M | +2.95% |
| Q2 2023 | 2023-06-30 | $341.5M | −$43.9M | −11.38% |
| Q1 2023 | 2023-03-31 | $353.0M | −$15.6M | −4.24% |
| Q4 2022 | 2022-12-31 | $364.0M | −$15.8M | −4.16% |
| Q3 2022 | 2022-09-30 | $375.8M | −$15.3M | −3.92% |
| Q2 2022 | 2022-06-30 | $385.4M | −$11.5M | −2.89% |
| Q1 2022 | 2022-03-31 | $368.6M | — | — |
| Q4 2021 | 2021-12-31 | $379.8M | $363.6M | +2242.13% |
| Q3 2021 | 2021-09-30 | $391.1M | — | — |
| Q2 2021 | 2021-06-30 | $396.8M | — | — |
| Q4 2020 | 2020-12-31 | $16.2M | — | — |
Janux Therapeutics total assets trends
Over the last five fiscal years, Janux Therapeutics's total assets increased from $16.2M to $1.00B, a change of $985.3M. The latest reported quarter, Q2 2026, shows $1.01B.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Janux Therapeutics source filings ↗